FFS. Nope I haven't changed my view that we are testing the lows on the S&P ...with even a test of S&P 4,000 a distinct probability . A Crash ala 1929 is IMHO very very unlikely .
As I posted earlier today regarding AMRN
Based on that I'll continue to add ...today at $2.6
My best guess is that Vazkepa will be reimbursed for secondary prevention in the UK / EU . That other studies , RESPECT EPA and the CAD portion of MITIGATE will confirm clinically important CV risk reduction using Vascepa ( even if not to the same degree as in the R-IT trial )
So as stated earlier ..I was buying today ...somehow thats seen by some here as spreading FUD !!!
Then important role of Technical Analysis Alexander Elder:
The key principle is to use fundamental information as an idea generator and technical studies as a trigger. The technical can either release you to pursue that trade or stop you from going any further. No matter how good a fundamental story, if the technical factors do not confirm it, there is no trade. This rule applies to both bullish and bearish fundamental information.When the fundamentals suggest a trade and technical factors confirm that signal, you have a very powerful combination. -- Fly Fishing The Stock Market
Unfortunately, for both the general market and AMRN, both fundamentals and technicals aver been in bearish sync to the downside, hence the falling knife.